https://orcid.org/0000-0002-8810-5493
References
- Choe SA, Seol HJ, Kwon JY, et al. Clinical practice guidelines for prenatal aneuploidy screening and diagnostic testing from korean society of Maternal-Fetal medicine: (1) prenatal aneuploidy screening. J Korean Med Sci. 2021;36(4):e27.
- Gadsbøll K, Petersen OB, Gatinois V, NIPT-map Study Group, et al. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99(6):722–730.
- Crombag NM, Bensing JM, Iedema-Kuiper R, et al. Determinants affecting pregnant women’s utilization of prenatal screening for down syndrome: a review of the literature. J Matern Fetal Neonatal Med. 2013;26(17):1676–1681.
- Huang W-H, Shih S-F, Lin C-L, et al. Pregnant women’s attitudes and decision-making regarding prenatal down syndrome screening and diagnosis: scale development and validation. BMC Pregnancy Childbirth. 2020;20(1):407.
- Pop-Tudose ME, Armean P, Pop IV. Prenatal screening for down syndrome: popularity, perceptions and factors associated with acceptance or refusal of testing. J Matern Fetal Neonatal Med. 2021;0(0):1–5.
- Haidar H, Le Clerc-Blain J, Vanstone M, et al. A qualitative study of women and partners from Lebanon and Quebec regarding an expanded scope of noninvasive prenatal testing. BMC Pregnancy Childbirth. 2021;21(1):54.